Table 1 Clinico-pathological features of the series. Numbers in columns refer to the number of individual lesions and to the number of tissue samples (parenthesis).
From: Quantitative evaluation of RASSF1Amethylation in the non-lesional, regenerative and neoplastic liver
Hepatitic Livers | |||||||||
|---|---|---|---|---|---|---|---|---|---|
Pts No | Age | Sex | Etiology | HCC n = 26 (30) | HN n = 45 (45) | HA n = 5 (13) | FNH n = 8 (22) | Cirrhosis n = 37 (39) | NLL n = 13 (34) |
1 | 70 | M | HBV | 1 (1) | -- | -- | -- | 1 (1) | -- |
2 | 48 | M | HBV | 1 (1) | 2 (2) | -- | -- | 1 (1) | -- |
3 | 50 | M | HBV | -- | 2 (2) | -- | -- | 1 (1) | -- |
4 | 41 | M | HBV | -- | 1 (1) | -- | -- | 1 (1) | -- |
5 | 41 | M | HBV | -- | 3 (3) | -- | -- | 1 (1) | -- |
6 | 59 | M | HCV | -- | 2 (2) | -- | -- | 1 (1) | -- |
7 | 56 | M | HCV | -- | 1 (1) | -- | -- | 1 (1) | -- |
8 | 58 | M | HCV | -- | 1 (1) | -- | -- | 1 (1) | -- |
9 | 75 | F | HCV | 1 (4) | 3 (3) | -- | -- | 1 (1) | -- |
10 | 42 | M | HCV | 1 (1) | 2 (2) | -- | -- | 1 (1) | -- |
11 | 59 | F | HCV | 1 (2) | 1 (1) | -- | -- | 1 (1) | -- |
12 | 71 | F | HCV | 1 (1) | 2 (2) | -- | -- | 1 (1) | -- |
13 | 71 | F | HCV | 1 (1) | 3 (3) | -- | -- | 1 (2) | -- |
14 | 57 | M | HCV | 1 (1) | -- | -- | -- | 1 (1) | -- |
15 | 62 | F | HCV | 1 (1) | -- | -- | -- | 1 (1) | -- |
16 | 67 | M | HCV | 1 (1) | -- | -- | -- | 1 (1) | -- |
17 | 74 | M | HCV | 1 (1) | -- | -- | -- | 1 (1) | -- |
18 | 67 | M | HCV | 1 (1) | -- | -- | -- | 1 (1) | -- |
19 | 70 | F | HCV | 1 (1) | -- | -- | -- | 1 (1) | -- |
20 | 69 | M | HCV | 1 (1) | -- | -- | -- | 1 (1) | -- |
21 | 68 | F | HCV | 1 (1) | -- | -- | -- | 1 (1) | -- |
22 | 54 | M | HBV/HCV | -- | 2 (2) | -- | -- | 1 (1) | -- |
23 | 49 | M | HBV/HDV | 1 (1) | 1 (1) | -- | -- | 1 (1) | -- |
24 | 53 | M | HBV/HDV | -- | 3 (3) | -- | -- | 1 (1) | -- |
25 | 52 | F | HBV/HDV | -- | 4 (4) | -- | -- | 1 (1) | -- |
26 | 62 | M | HBV/HDV/HCV | 1 (1) | 5 (5) | -- | -- | -- | -- |
27 | 65 | M | Cryptogenic | 1 (1) | -- | -- | -- | 1 (1) | -- |
28 | 48 | F | Cryptogenic | 1 (1) | -- | -- | -- | 1 (1) | -- |
29 | 72 | M | Cryptogenic | 1 (1) | -- | -- | -- | 1 (1) | -- |
30 | 57 | M | Cryptogenic | -- | 2 (2) | -- | -- | 1 (1) | -- |
31 | 51 | F | Cryptogenic | 1 (1) | -- | -- | -- | 1 (1) | -- |
32 | 73 | M | Cryptogenic | 1 (1) | -- | -- | -- | 1 (1) | -- |
33 | 70 | F | Cryptogenic | 1 (1) | -- | -- | -- | 1 (1) | -- |
34 | 49 | M | Cryptogenic | -- | 3 (3) | -- | -- | 1 (2) | -- |
35 | 69 | M | Cryptogenic | 1 (1) | 1 (1) | -- | -- | 1 (1) | -- |
36 | 22 | F | Wilson desease | -- | 1 (1) | -- | -- | 1 (1) | -- |
37 | 65 | M | Alcholic | 1 (1) | -- | -- | -- | 1 (1) | -- |
38 | 70 | M | Haemocromatosis | 1 (1) | -- | -- | -- | 1 (1) | -- |
Non-Hepatitic Livers | |||||||||
39 | 28 | M | -- | -- | -- | -- | 1 (3) | -- | 1 (4) |
40 | 30 | F | -- | -- | -- | -- | 1 (1) | -- | 1 (1) |
41 | 39 | M | -- | -- | -- | -- | 1 (4) | -- | 1 (4) |
42 | 47 | F | -- | -- | -- | -- | 1 (3) | -- | 1 (4) |
43 | 26 | F | -- | -- | -- | -- | 1 (1) | -- | 1 (1) |
44 | 33 | M | -- | -- | -- | -- | 1 (5) | -- | 1 (4) |
45 | 54 | M | -- | -- | -- | -- | 1 (4) | -- | 1 (4) |
46 | 33 | F | -- | -- | -- | -- | 1 (1) | -- | 1 (1) |
47 | 44 | F | -- | -- | -- | 1 (4) | -- | -- | 1 (3) |
48 | 36 | F | -- | -- | -- | 1 (1) | -- | -- | 1 (1) |
49 | 34 | F | -- | -- | -- | 1 (3) | -- | -- | 1 (2) |
50 | 38 | F | -- | -- | -- | 1 (4)* | -- | -- | 1 (4) |
51 | 40 | F | -- | -- | -- | 1 (1) | -- | -- | 1 (1) |